Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,940.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 2,205.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 34,555
  • Market Cap: £4,304.57m
  • RiskGrade: 125

Wednesday broker round-up

By Caoimhe Toman

Date: Wednesday 31 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Hikma: Jefferies upgrades to buy with a target price of 2,870p.

Vistry Group: Berenberg reiterates buy with a target price of 1,270p.

Hunting Group: Canaccord reiterates buy with a target price of 320p.

Sumo Group: Canaccord reiterates buy with a target price of 390p.

Qinetiq: JP Morgan reiterates neutral with a target price of 330p.

Auto Trader: JP Morgan reiterates underweight with a target price of 490p.

BAE Systems: Deutsche Bank reiterates buy with a target price of 670p.

AG Barr: Liberum reiterates buy with a target price of 625p.

Wincanton: Liberum reiterates buy with a target price of 445p.

Glencore: Jefferies reiterates buy with a target price of 450p.

Travis Perkins: Jefferies reiterates buy with a target price of 1,829p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,940.00p
Change Today -1.00p
% Change -0.05 %
52 Week High 2,205.00p
52 Week Low 1,722.00p
Volume 34,555
Shares Issued 221.89m
Market Cap £4,304.57m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.99% below the market average50.99% below the market average50.99% below the market average50.99% below the market average50.99% below the market average
9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average
Price Trend
47.93% above the market average47.93% above the market average47.93% above the market average47.93% above the market average47.93% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
8.77% above the market average8.77% above the market average8.77% above the market average8.77% above the market average8.77% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average32.44% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 26-Jun-2024

Time Volume / Share Price
11:21 32 @ 1,939.00p
11:16 22 @ 1,940.00p
11:15 55 @ 1,939.00p
11:13 138 @ 1,940.00p
11:13 12 @ 1,939.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page